Global C-Arms Market Size, Trends & Growth Opportunity and By Type (Fixed C-Arms and Mobile C-Arms), By Application (Cardiology, Gastroenterology, Orthopedics and Trauma, Radiology/ Oncology, and Others), By Region and Forecast till 2027.

Global C-Arms Market Size, Trends & Growth Opportunity and By Type (Fixed C-Arms and Mobile C-Arms), By Application (Cardiology, Gastroenterology, Orthopedics and Trauma, Radiology/ Oncology, and Others), By Region and Forecast till 2027.

Global C-Arms Market

The Global C-Arms Market is expected to grow from US$ 1,796.92 Million in 2021 to US$ 2,435.7 Million by 2027; it is estimated to grow at a CAGR of 5.20% from 2022 to 2027.

C-Arm is a type of medical imaging device which is based on X-ray technology. This device includes rotating flat detector that provides imaging versatility right in the surgical suite, regardless of the complexity of extremity procedure.

Market Drivers

Increase in geriatric population is the key driving factor which is expected to boost the global C-arms market growth. Furthermore, rise in patient awareness will have the positive impact on market growth. Moreover, rise in level of accuracy with 3D visualization which is expected to led the demand for C-arms during this forecast period. In addition to that, increase in prevalence of orthopedic injuries and rise in foreign investments will drive the market growth in near future. Also, increase in adoption of minimally invasive procedures will propel the market growth. For instance, in April Siemens had launched Cios alpha for treatment of endovascular and vascular procedures.

Market restraints

However, high procedural and equipment cost are the major challenging factors which are expected to hamper the global c-arm market growth. Also, growing use of refurnished devices will affect the market growth of Global C-Arms Market.

Market Opportunities:

In addition, a rise in public-private funding for targeted research initiatives, the appeal of customised medicine, and an increase in product innovations and development due to global technology improvements will create lucrative prospects for market participants between 2022 and 2029.

Impact of Covid-19

The market has been severely and unfavourably affected by COVID-19. The amount of money allocated for research and development projects has been drastically cut back. Market demand and supply were degraded by supply network interruptions. During this phase, superfluous operations were stopped by refocusing on the critical healthcare procedures. The non-urgent medical operations were significantly delayed. A number of precautionary lockdowns have caused significant interruptions to their own industrial and supply-chain operations, which has made the issue worse. During the epidemic, all of this turned out to be a problem for the market.

Segmentation By Type: C-Arms Market is classified on the basis of Type into Fixed C-Arms and Mobile C-Arms.

Segmentation By Application: C-Arms Market is classified on the basis of Application into Cardiology, Gastroenterology, Orthopedics and Trauma, Radiology/ Oncology, and Others.

Segmentation By Region: C-Arms Market is classified on the basis of Region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Over the course of the forecast period, North America is anticipated to account for a sizable portion of the market, with the United States accounting for the majority of that share. This significant portion is attributable to the United States' high standards for healthcare infrastructure, frequent diagnostic testing, growing elderly population, and rising chronic illness prevalence.

Market Key Players

The key players in Global C-Arms Market are Assing S.p.A, GE Healthcare, AADCO Medical, Inc, Shimadzu Corporation, Villa Sistemi Medicali Spa, ITALRAY, Hologic Inc., Koninklijke Philips N.V., Canon Inc, Siemens Healthcare GmbH, and Ziehm Imaging.

Industrial Development

• Ziehm Imaging announced in August 2020 that it has acquired Therenva, a provider of planning and imaging software solutions for cardiovascular treatments. With this acquisition, Ziehm Imaging hopes to promote Therenva's current product line across the globe using its extensive mobile C-arm system distribution network.
• Koninklijke Philips NV stated in January 2022 that their mobile C-Arm System Series - Zenition would use cloud-based AI and 3D mapping. After incorporating cloud-based AI and 3D mapping into the C-Arm system, Koninklijke Philips NV anticipates increased workflow efficiency and better endovascular treatment outcomes.